EPO and anemia: In men aged ≥ 85, anemia significantly elevates mortality risk through synergistic mechanisms: chronic inflammation suppresses erythropoiesis and iron metabolism, while age-related testosterone deficiency exacerbates erythropoietin resistance and sarcopenia, impairing oxygen delivery and physical resilience.